Prometheus Biosciences In... (RXDX)
NASDAQ: RXDX
· Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 10:00 PM
Prometheus Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 113.34M | 292.42M | 78.41M | 95.96M | 227.03M | 257.25M | 279.12M | 304.39M | 311.23M | 54.2M |
Short-Term Investments | 600.33M | 403.33M | 181.84M | 115.82M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 971K | 971K | 971K | 971K | 1.54M | 971K | 468K | 468K | 468K | 1.73M |
Receivables | n/a | 1.03M | 941K | 1.86M | 1.29M | 1.08M | 679K | 217K | 973K | 1.09M |
Inventory | n/a | -1.03M | n/a | n/a | n/a | -1.08M | n/a | n/a | n/a | n/a |
Other Current Assets | 12.73M | 12.4M | 4.87M | 5.7M | 6.66M | 8.13M | 7.31M | 6.98M | 6.42M | 2.17M |
Total Current Assets | 726.4M | 708.15M | 266.06M | 219.35M | 234.98M | 265.38M | 287.11M | 311.59M | 318.62M | 57.46M |
Property-Plant & Equipment | 31.04M | 31.65M | 31.59M | 17.27M | 17.06M | 1.45M | 1.36M | 1.11M | 913K | 447K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 32.01M | 32.62M | 32.56M | 18.24M | 18.6M | 2.42M | 1.83M | 1.58M | 1.38M | 2.18M |
Total Assets | 758.41M | 740.77M | 298.62M | 237.59M | 253.58M | 267.8M | 288.94M | 313.17M | 320M | 59.63M |
Account Payables | 1.16M | 762K | 1.08M | 462K | 1.81M | 1.15M | 1.66M | 2.25M | 2.08M | 958K |
Deferred Revenue | 1.15M | 1.3M | 1.54M | 1.78M | 2.13M | 3.67M | 3.56M | 2.69M | 2.42M | 1.88M |
Short-Term Debt | 3.48M | 3.22M | 2.55M | 1.2M | 891K | n/a | n/a | 7.4M | n/a | n/a |
Other Current Liabilities | 13.55M | 17.54M | 18.61M | 13.02M | 12.49M | 11.62M | 9.87M | 5.37M | 4.29M | 12.42M |
Total Current Liabilities | 19.34M | 22.82M | 23.78M | 16.47M | 17.32M | 16.44M | 15.09M | 17.7M | 8.79M | 15.26M |
Long-Term Debt | 25.98M | 26.32M | 26.66M | 13.56M | 13.73M | n/a | n/a | n/a | 7.37M | 7.4M |
Other Long-Term Liabilities | 41.46M | 41.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 129.92M |
Total Long-Term Liabilities | 41.46M | 41.99M | 42.3M | 29.29M | 29.53M | 16.2M | 11.74M | 13.04M | 11.02M | 141.92M |
Total Liabilities | 60.8M | 64.81M | 66.08M | 45.76M | 46.86M | 32.65M | 26.84M | 30.74M | 19.8M | 157.17M |
Total Debt | 29.46M | 29.54M | 29.21M | 14.76M | 14.62M | n/a | n/a | 7.4M | 7.37M | 7.4M |
Common Stock | 5K | 5K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | n/a |
Retained Earnings | -371.97M | -331.09M | -292.33M | -255.05M | -221.41M | -189.34M | -159.42M | -132.09M | -113.09M | -99.15M |
Comprehensive Income | -232K | -429K | -451K | -310K | n/a | n/a | -288.94M | -313.17M | -320M | n/a |
Shareholders Equity | 697.62M | 675.97M | 232.53M | 191.83M | 206.72M | 235.16M | 262.1M | 282.43M | 300.2M | -97.54M |
Total Investments | 600.33M | 403.33M | 181.84M | 115.82M | n/a | n/a | n/a | n/a | n/a | n/a |